Form 4: Core Scientific CEO Boosts Stake, Manages Tax

Core Scientific CEO Adam Taylor Sullivan reported an increase in beneficial ownership through RSU vesting and an in-kind distribution, alongside a sale to cover tax obligations.

Summary

• Adam Taylor Sullivan, Chief Executive Officer and Director of Core Scientific, Inc. (CORZ), reported transactions on December 31, 2025.
• Acquired 159,308 shares of Common Stock due to the 300% vesting of performance-based restricted stock units (RSUs) granted on June 14, 2024.
• Acquired an additional 336 shares of Common Stock on December 24, 2025, from an in-kind distribution by XMS XPDI Sponsor Holdings LLC, which was exempt from Section 16 reporting.
• Disposed of 117,540 shares of Common Stock at a price of $15.08 per share to satisfy withholding tax obligations upon the vesting of restricted stock units.
• Beneficial ownership after these reported transactions is 4,405,704 shares of Common Stock.

Sentiment

Score: 7

Explanation: The net increase in beneficial ownership by the CEO, coupled with the 300% vesting of performance-based RSUs, suggests positive performance and continued insider confidence, despite the routine tax-related sale.

Positives

• CEO Adam Taylor Sullivan's beneficial ownership increased by a net of 42,004 shares (159,308 + 336 117,540) after accounting for tax-related sales, indicating continued alignment with shareholder interests.
• The 300% vesting of performance-based restricted stock units suggests strong company performance against the RSU targets, exceeding initial expectations.

Negatives

• A significant number of shares (117,540) were sold to cover tax obligations, which, while a common practice, represents a direct sale of company stock by an insider.

Future Outlook

NA

Industry Context

This Form 4 filing details routine insider transactions for Core Scientific's CEO, Adam Taylor Sullivan. Such filings are standard for publicly traded companies and reflect executive compensation and tax management, rather than broader industry trends in the cryptocurrency mining or data center sectors.

Related Party Transactions

• The acquisition of 336 shares of Common Stock from an in-kind distribution by XMS XPDI Sponsor Holdings LLC could be considered a related party transaction, though it is exempt from Section 16 reporting under Rule 16a-9.

Stakeholder Impact

• Shareholders may view the net increase in the CEO's beneficial ownership as a positive signal of management's continued alignment with shareholder interests and confidence in the company's future performance.
• The 300% vesting of performance-based RSUs indicates that the company met or exceeded specific performance targets, which is generally positive for shareholders.

Key Dates

Recommendation

This Form 4 primarily details routine insider transactions related to executive compensation and tax obligations. While the net increase in the CEO's beneficial ownership and the high vesting percentage of performance-based RSUs are positive indicators of management confidence and past performance, the filing itself does not contain new strategic or financial information significant enough to warrant a change from a 'hold' position based solely on this report. Investors should consider broader company fundamentals and market conditions.

Keywords

Core Scientific, CORZ, Adam Taylor Sullivan, Insider Trading, Form 4, Restricted Stock Units, RSU Vesting, CEO Stock Ownership, Beneficial Ownership, Tax Withholding